1. Docetaxel suppressed cell proliferation through Smad3/HIF-1α-mediated glycolysis in prostate cancer cells
   Junming Peng et al, 2022, Cell Communication and Signaling CrossRef
2. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer
   Jiayu Zhang et al, 2020, BMC Medical Genomics CrossRef
3. Regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance
   Yeelon Yeoh et al, 2021, PeerJ CrossRef
4. IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm
   Elena De Mattia et al, 2021, Cancers CrossRef
5. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
   D J Junk et al, 2017, Oncogene CrossRef
6. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence
   Benjamin L. Bryson et al, 2017, Cell Cycle CrossRef
7. MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
   Amir Sadra Zangouei et al, 2021, Cancer Cell International CrossRef
8. Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
   Farah Ballout et al, 2024, Clinical Cancer Research CrossRef
9. Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice
   T Feng et al, 2017, Oncogenesis CrossRef
10. SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
    Elena De Mattia et al, 2021, Frontiers in Pharmacology CrossRef
11. Retracted: Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway
    Qiuhuan Li et al, 2019, Journal of Cellular Biochemistry CrossRef
12. Theragnosis by a miR-141-3p molecular beacon: simultaneous detection and sensitization of 5-fluorouracil resistant colorectal cancer cells through the activation of the TRIM13-associated apoptotic pathway
    Sung Ung Moon et al, 2019, Chemical Communications CrossRef
13. Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications
    Diana L. Hanna et al, 2016, Expert Review of Clinical Pharmacology CrossRef
14. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers
    Xiaoqun Lv et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
15. Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition
    Zhenlv Lin et al, 2019, Molecular Medicine Reports CrossRef